Category:Antineoplastic drugs
 | This category reflects the organization of Anatomical Therapeutic Chemical Classification System code L01. Generally, drugs outlined within the ATC code L01 should be included in this category. Please see WP:PHARM:CAT for more information. |
Wikimedia Commons has media related to Antineoplastic agents.
Subcategories
This category has the following 17 subcategories, out of 17 total.
A
- Antibody-drug conjugates (57 P)
B
C
D
E
- Experimental cancer drugs (259 P)
H
M
- Mitotic inhibitors (31 P)
- Monoclonal antibodies for tumors (134 P)
P
- Photosensitizing agents (8 P)
- Proteasome inhibitors (10 P)
T
Pages in category "Antineoplastic drugs"
The following 180 pages are in this category, out of 180 total. This list may not reflect recent changes.
A
- Abexinostat
- Acalabrutinib
- Aceglatone
- Acutissimin A
- Adagrasib
- Afatinib
- Alestramustine
- Alitretinoin
- AM-251 (drug)
- Aminolevulinic acid
- Amphinex
- Amsacrine
- Anagrelide
- Angiozyme
- Anthramycin
- Antibody–drug conjugate
- Anticarcinogen
- List of antineoplastic agents
- Apaziquone
- Arsenic trioxide
- Asparaginase
- Asunercept
- Atrimustine
- Axicabtagene ciloleucel
- Azaserine
C
D
E
H
I
L
M
P
S
T
- Talazoparib
- Talimogene laherparepvec
- Tamibarotene
- Targeted therapy
- Tazemetostat
- Tebentafusp
- Tegafur/gimeracil/oteracil
- Temsirolimus
- Tepotinib
- Tesmilifene
- Testifenon
- Tigilanol tiglate
- Tisagenlecleucel
- Toripalimab
- Trabectedin
- Trastuzumab/hyaluronidase
- Tretinoin
- Trifluridine
- Trifluridine/tipiracil
- Tucatinib